Atrium Health Levine Cancer

Atrium Health Levine Cancer At Atrium Health, now part of Advocate Health, we’re driven to give all people access to the best cancer care available.
(667)

Together, we are Atrium Health Levine Cancer – an integrated cancer program that unites cancer services at Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist under one name – The largest cancer program in the Carolinas. Fueled by the research and innovation of our National Cancer Institute-designated Atrium Health Wake Forest Baptist Comprehensive Cancer Center, enriched with access to highly impactful clinical trials, and supported by Wake Forest University School of Medicine, the new Levine Cancer creates a patient-centered experience unlike anything else in the region.

03/09/2026
03/05/2026

New research highlights a promising new approach to treating brain metastases, one of the most difficult complications of lung cancer.

The study by Wake Forest University School of Medicine was published in Nature Biomedical Engineering. In it, researchers engineered macrophages, immune cells that naturally cross the bloodbrain barrier, to recognize and attack cancer cells in the brain. These CAR macrophages successfully entered brain tumor sites, reduced tumor growth, and extended survival in early models, with fewer signs of toxicity than CART approaches.

The findings point to a potential new path for immunotherapy in the brain, where treatment options remain limited.

Learn more. https://bit.ly/4d0fkIX

02/26/2026
02/25/2026
02/19/2026
02/13/2026

Atrium Health Levine Cancer’s Survivorship Clinic is a critical part of the Department of Supportive Care and offers a place for cancer survivors to heal and thrive in recovery.

02/12/2026

A global study led by Wake Forest University School of Medicine and Atrium Health Levine Cancer shows a major advance for patients with highrisk essential thrombocythaemia (ET) — a rare blood cancer with limited treatment options.

The SURPASSET clinical trial found that ropeginterferon alfa2b delivers significantly better disease control, fewer symptoms and fewer serious complications compared to the current secondline therapy for patients who can’t tolerate hydroxyurea.

With the FDA now reviewing an application to expand the use of ropeginterferon alfa2b for ET, this study marks a meaningful step forward for patients and clinicians.

Learn more.
https://newsroom.wakehealth.edu/news-releases/2026/02/global-study-marks-major-treatment-advance-for-blood-cancer

02/10/2026

Cancer treatments can save lives, but they can also impact the heart. Learn why heart health is essential for cancer patients and survivors and how cardio-oncologists help protect you.

02/10/2026
01/21/2026

After completing two courses of chemotherapy and a stem cell transplant for Hodgkin lymphoma, 15-year-old Ava Schmid became the 100th patient treated at Atrium Health Levine Cancer’s Proton & Advanced Radiation Center.

01/16/2026

Address

1021 Morehead Medical Drive
Charlotte, NC
28204

Telephone

+19804422000

Website

Alerts

Be the first to know and let us send you an email when Atrium Health Levine Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Atrium Health Levine Cancer:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category